Exploring how therapies and medications affect youth with Autism Spectrum Disorders
The interplay of behavioral therapies, pharmacological treatments and psychiatric adverse events among Youth with Autism Spectrum Disorders
This study looks at how different therapies and medications help young people with Autism Spectrum Disorders, especially focusing on any side effects they might experience, while also considering how things like race, gender, and income can affect their treatment during tough times like the COVID-19 pandemic.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pennsylvania State Univ Hershey Med Ctr NIH-funded |
| Lab location | 1 site (Hershey, United States) |
| Project ID | NIH-11056764 on NIH RePORTER |
What this research studies
This research investigates the effects of behavioral therapies and pharmacological treatments on youth with Autism Spectrum Disorders (ASD), particularly focusing on the psychiatric adverse events that may arise. It aims to understand how these treatments are utilized in real-world settings, considering the diverse needs of individuals with ASD and the impact of factors such as race, gender, and socioeconomic status. The study will analyze treatment patterns and the potential negative effects of polypharmacy on the effectiveness of behavioral therapies, especially in the context of increased stress due to the COVID-19 pandemic.
Who could benefit from this research
Good fit: Ideal candidates for this research are youth diagnosed with Autism Spectrum Disorders who may also be experiencing comorbid psychiatric conditions.
Not a fit: Patients without a diagnosis of Autism Spectrum Disorders or those who do not have any comorbid psychiatric conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for youth with ASD, enhancing their overall health and well-being.
How similar studies have performed: While there is ongoing research in the area of ASD treatment, this study addresses specific gaps related to the interplay of therapies and medications, making it a novel approach.
Where this research is happening
Hershey, United States
- Pennsylvania State Univ Hershey Med Ctr — Hershey, United States (Active)
Researchers
- Principal investigator: Liu, Guodong — Pennsylvania State Univ Hershey Med Ctr
- Study coordinator: Liu, Guodong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.